Polyrizon partners with Clearmind to develop intranasal MEAI formulation
Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation| (NASDAQ: CMND) | Delayed: 3.07 -0.07 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.14 | 52 Week High | $ | |||
| Open | $3.15 | 52 Week Low | $ | |||
| Day High | $3.44 | P/E | N/A | |||
| Day Low | $2.94 | EPS | $ | |||
| Volume | 1,281,676 | |||||
| (NASDAQ: PLRZ) | Delayed: 13.42 +0.19 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.23 | 52 Week High | $ | |||
| Open | $13.52 | 52 Week Low | $ | |||
| Day High | $13.52 | P/E | N/A | |||
| Day Low | $12.50 | EPS | $ | |||
| Volume | 66,731 | |||||

